- Home
- CVAC vs BHK Comparison
CVAC vs BHK Comparison
Compare CVAC & BHK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CVAC | BHK |
|---|---|---|
| Founded | 2000 | 2001 |
| Country | Germany | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 679.6M |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | CVAC | BHK |
|---|---|---|
| Price | $4.81 | $9.50 |
| Analyst Decision | Hold | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $6.83 | N/A |
| AVG Volume (30 Days) | ★ 1.7M | 188.3K |
| Earning Date | 11-24-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 8.34% |
| EPS Growth | ★ 94.02 | N/A |
| EPS | 0.94 | ★ 1.03 |
| Revenue | ★ $83,000,117.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $23.40 | N/A |
| P/E Ratio | ★ $5.15 | $10.42 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.48 | $9.02 |
| 52 Week High | $5.72 | $11.09 |
Technical Indicators
Market Signals| Indicator | CVAC | BHK |
|---|---|---|
| Relative Strength Index (RSI) | 29.80 | 42.57 |
| Support Level | $5.05 | $9.45 |
| Resistance Level | $5.20 | $9.52 |
| Average True Range (ATR) | 0.13 | 0.07 |
| MACD | -0.03 | 0.00 |
| Stochastic Oscillator | 4.49 | 24.77 |
Price Performance
Historical ComparisonAbout CVAC CureVac N.V.
CureVac NV is a biopharmaceutical company headquartered in Germany that is developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA) that has the potential to improve the lives of people. CureVac had a collaboration with GSK to develop second-generation seasonal influenza and COVID-19 vaccines and an avian influenza vaccine. The company's other pipeline candidates include mRNA vaccines for oncology and molecular therapies spanning tumors, liver, and ocular diseases.
About BHK Blackrock Core Bond Trust
Blackrock Core Bond Trust is a closed-ended management investment company. Its objective is to provide current income and capital appreciation. The trust seeks to achieve its investment objective by investing a majority of its managed assets in bonds that are investment-grade quality at the time of investment. The trust's investments will include a broad range of bonds, including corporate bonds, U.S. government and agency securities and mortgage-related securities.